Biomarkers in COPD: the search continues!


In a working group of the National Institutes of Health focusing on biomarkers and surrogate end-points, a biomarker was defined as a “characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention” [1]. In the same document, the National… (More)
DOI: 10.1183/09031936.00236314


  • Presentations referencing similar topics